<DOC>
	<DOCNO>NCT00063713</DOCNO>
	<brief_summary>The purpose study find whether treatment VELCADE increase time take lymphoma get worse .</brief_summary>
	<brief_title>VELCADE Subjects With Relapsed Refractory Mantle Cell Lymphoma</brief_title>
	<detailed_description>VELCADE approve multiple myeloma patient receive two prior therapy disease come back got bad second therapy . VELCADE currently study type cancer .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Inclusion Criteria 18 year age old Confirmed diagnosis mantle cell lymphoma Documented relapse progressive disease follow 1 2 prior line anticancer therapy . At least one regimens must include anthracycline mitoxantrone . Relapsed progressive disease , since last therapy must document new lesion objective evidence progression exist lesion . At least 1 measurable evaluable site disease Voluntary consent Exclusion Criteria Previous treatment VELCADE Any experimental anticancer therapy within 3 week first dose study drug Radiation therapy within 3 week first dose study drug Major surgery 2 week first dose study drug Rituximab , Campath , unconjugated therapeutic antibody within 4 week first dose study drug Radioimmunotherapy toxin immunoconjugates Zevalin Bexxar within 10 week first dose study drug History allergic reaction boron mannitol compound Diagnosed treat another malignancy mantle cell lymphoma 5 year first dose study drug Active systemic infection require treatment Women patient must pregnant breastfeeding , confirm pregnancy test obtain screening ( test require woman postmenopausal surgically sterile ) Serious medical psychiatric illness likely interfere participation clinical study Concurrent treatment another investigational drug participation nontreatment study allow interferes participation clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>